DaVita Collaborates with Shanghai Hospital to Innovate Kidney Care Delivery in China
November 13, 2013 | Press Releases
Under the agreement, DaVita will provide consultation services to the public hospital on advanced management processes for its renal outpatient visits and dialysis treatments. Additionally, DaVita and the hospital will upgrade clinic technology, expand the number of dialysis stations, and bring its industry-leading quality of care and resulting clinical outcomes to the hospital.
“In support of Chinese health care reform, DaVita’s objective is to pilot a sustainable, cost-effective and high-quality renal care and dialysis network with Antu Hospital and within the Yangpu District,” said Atul Mathur, president of DaVita’s Asia-Pacific operations. “We anticipate this collaboration will serve as a model for other communities in China.”
The arrangement provides DaVita a platform for research aimed at improving patient health outcomes and maximizing cost effectiveness for the Chinese health care system.
“The end stage renal disease population in China is the ultimate beneficiary of this collaboration,” said Dennis Kogod, DaVita’s chief operating officer. “Not only does it promote health care quality improvement, safety and therapeutic effectiveness, we believe it will minimize medical expenses and lead to overall quality of life improvement for patients.”
Last year DaVita entered China with a joint venture deal with 3sBio Inc., a leading Chinese biotechnology developer of biopharmaceutical products, providing dialysis treatments in northeastern China.
DaVita and DaVita HealthCare Partners are trademarks or registered trademarks of DaVita HealthCare Partners Inc. All other trademarks are the property of their respective owners.